Detalles de la búsqueda
1.
Adverse outcome associated with daratumumab-based treatments in relapsed/refractory multiple myeloma patients with amplification of chromosome arm 1q21: a single-center retrospective experience.
Ann Hematol
; 101(12): 2777-2779, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36104630
2.
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
Genes Chromosomes Cancer
; 50(8): 633-43, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21563234
3.
Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma.
Haematologica
; 100(11): e467-70, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26206802
4.
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia.
Oncotarget
; 10(8): 869-882, 2019 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30783516
5.
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma.
Eur J Haematol
; 86(4): 352-5, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21226763
6.
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies.
Cancer Genet Cytogenet
; 200(1): 1-7, 2010 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20513527
7.
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.
Leuk Lymphoma
; 56(11): 3222-6, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25813079
Resultados
1 -
7
de 7
1
Próxima >
>>